ClinicalTrials.Veeva

Menu

Sleep and Cerebral Responses to High Altitude (VALLOT 2011)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Unknown

Conditions

High Altitude Pulmonary Edema
High Altitude Cerebral Edema
Acute Mountain Sickness

Study type

Observational

Funder types

Other

Identifiers

NCT01565603
RCB 2011-A00071-40

Details and patient eligibility

About

Mechanisms underlying high-altitude intolerance as well as exercise performance limitation in hypoxia still remain to be fully understood. Recent data suggest that sleep disturbances on one hand and cerebral perturbations on teh other hand may be key mechanisms. The investigators evaluated 12 healthy subjects at sea level and at 4400 m of altitude for 7 days in order to better describe sleep and cerebral responses. The investigators hypothesized that sleep and cerebral disturbances play a critical role for the developement of acute mountain sickness and for exercise performance limitation during acute high-altitude exposure.

Enrollment

12 patients

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 to 50 yrs old
  • Male

Exclusion criteria

  • Respiratory, cardiac, metabolic or neuromuscular diseases
  • History of severe acute mountain sickness

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems